Literature DB >> 24634123

MicroRNAs function primarily in the pathogenesis of human anencephaly via the mitogen-activated protein kinase signaling pathway.

W D Zhang1, X Yu1, X Fu1, S Huang1, S J Jin1, Q Ning2, X P Luo3.   

Abstract

Anencephaly is one of the most serious forms of neural tube defects (NTDs), a group of congenital central nervous system (CNS) malformations. MicroRNAs (miRNAs) are involved in diverse biological processes via the post-transcriptional regulation of target mRNAs. Although miRNAs play important roles in the development of mammalian CNS, their function in human NTDs remains unknown. Using a miRNA microarray, we identified a unique expression profile in fetal anencephalic brain tissues, characterized by 70 upregulated miRNAs (ratio ≥ 2) and 7 downregulated miRNAs (ratio ≤ 0.5) compared with healthy human samples. Ten miRNAs with altered expression were selected from the microarray findings for validation with real-time quantitative reverse transcription-polymerase chain reaction. We found that in anencephalic tissues, miR-22, miR-23a, miR-34a, miR-103, miR-125a, miR-132, miR-134, miR-138, and miR-185 were significantly upregulated, while miR-149 was significantly downregulated. Furthermore, 459 potential target genes within the validated miRNAs were revealed using combined four target prediction algorithms in the human genome, and subsequently analyzed with the Molecule Annotation System 3.0. A total of 119 target genes were ultimately identified, including those involved in 22 singular annotations (i.e., transcription, signal transduction, and cell cycle) and 55 functional pathways [i.e., mitogen-activated protein kinase (MAPK) signaling pathway, and actin cytoskeleton regulation]. Six target genes (HNRPU, JAG1, FMR1, EGR3, RUNX1T1, and NDEL1) were chosen as candidate genes and associated with congenital birth abnormalities of the brain structure. Our results, therefore, suggest that miRNA maladjustment mainly contributes to the etiopathogenesis of anencephaly via the MAPK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24634123     DOI: 10.4238/2014.February.20.3

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

Review 1.  Finding the genetic mechanisms of folate deficiency and neural tube defects-Leaving no stone unturned.

Authors:  Kit Sing Au; Tina O Findley; Hope Northrup
Journal:  Am J Med Genet A       Date:  2017-09-25       Impact factor: 2.802

Review 2.  MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders.

Authors:  Seyed Hamidreza Rastegar-Moghaddam; Alireza Ebrahimzadeh-Bideskan; Sara Shahba; Amir Mohammad Malvandi; Abbas Mohammadipour
Journal:  Mol Neurobiol       Date:  2022-02-14       Impact factor: 5.590

3.  MicroRNA and mRNA Dysregulation in Astrocytes Infected with Zika Virus.

Authors:  Robert A Kozak; Anna Majer; Mia J Biondi; Sarah J Medina; Lee W Goneau; Babu V Sajesh; Jessy A Slota; Vanessa Zubach; Alberto Severini; David Safronetz; Shannon L Hiebert; Daniel R Beniac; Timothy F Booth; Stephanie A Booth; Gary P Kobinger
Journal:  Viruses       Date:  2017-10-14       Impact factor: 5.048

4.  The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature.

Authors:  Octavian Munteanu; Monica Mihaela Cîrstoiu; Florin Mihail Filipoiu; Maria Narcisa Neamţu; Irina Stavarache; Tiberiu Augustin Georgescu; Ovidiu Gabriel Bratu; Gabriela Iorgulescu; Roxana Elena Bohîlţea
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

5.  Altered microRNA expression profiles in a rat model of spina bifida.

Authors:  Pan Qin; Lin Li; Da Zhang; Qiu-Liang Liu; Xin-Rang Chen; He-Ying Yang; Ying-Zhong Fan; Jia-Xiang Wang
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.